Head-to-head · free

Siemens Healthineers AG vs SOPHiA GENETICS S.A.

SMMNY vs SOPH — return on capital, cash generation, margins and balance sheet side by side.

SMMNY

0 / 0

measures where SMMNY leads

SOPH

0 / 0

measures where SOPH leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureSMMNYSOPH
Revenue——
Net income——
Revenue growth (yearly, multi-year)——
Free cash flow——
Free cash flow margin——
Net cash / (debt)——
ROIC——
Return on equity—-110.0%
Gross margin—67.4%
Operating margin—-91.8%
Net debt / EBITDA—0.37x

Figures are as reported by each company; latest fiscal year shown.

Where Siemens Healthineers AG's cash went

Not reported yet.

Full SMMNY profile →

Where SOPHiA GENETICS S.A.'s cash went

Not reported yet.

Full SOPH profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons